Security key
98420P308
Xtant Medical Holdings, Inc. - Common Stock (XTNT)
CUSIP: 98420P308
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 96,332,001
- Total 13F value
- $45,274,819
- Share change
- -360,529
- SEC-reported price per share
- $0.47
- Number of holders
- 26
- Value change
- -$166,227
- Number of buys
- 6
- Number of sells
- 12
- Shares outstanding
- 140,036,400
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
26
Top holders
10
XTNT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Xtant Medical Holdings, Inc. SEC filings
Xtant Medical Holdings, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98420P308
Recent filing periods:
Ownership snapshot
Top reported holders of XTNT - Xtant Medical Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F
Lead comparable stake: 52%
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 52%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
52%
Nantahala Capital Management, LLC
8.1%
Altium Capital Management LLC
5.3%
VANGUARD GROUP INC
1.5%
RENAISSANCE TECHNOLOGIES LLC
0.57%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
52%
|
$32,389,764
73,114,592 shares
|
— | 31 Dec 2024 |
| Nantahala Capital Management, LLC |
13F
Company
|
8.1%
|
$5,047,542
11,394,000 shares
|
— | 31 Dec 2024 |
| Altium Capital Management LLC |
13F
Company
|
5.3%
|
$3,285,028
7,415,413 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
1.5%
|
$952,854
2,150,912 shares
|
— | 31 Dec 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.57%
|
$353,529
798,033 shares
|
— | 31 Dec 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.37%
|
$226,827
511,875 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
26
Shares
96,332,001
Rows available
26
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2026 Across Filers
Q1 2026 holders
34
Q1 2025 holders
26
Holder diff
-8
| Investor | Q1 2026 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend